Risk of Nerve Damage After Administration of an Inferior Alveolar Nerve Block Using 4% Articaine Versus 2% Lidocaine
Cleveland Dental Institute
Summary
This research aims to evaluate of the risk of nerve damage following the administration of articaine 4% and lidocaine 2% for Inferior Alveolar nerve Block (IANB). A Randomized Controlled Clinical Trial will be conducted where the patient will be randomly assigned to one the two groups; articaine 4% and Lidocaine 2%. The type of LA will be concealed to the operator, investigators and assessors. The patients will be monitored for any aigns of nerve parathesia for 3 months after the procedure.
Eligibility
- Age range
- 18–55 years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: * Patients with age between 18-55 years old * Patients need IANB * healthy patient Exclusion Criteria: * medical conditions * allergies * medications * pregnancy and breastfeeding * inability to provide informed consent * specific dental or medical history.
Interventions
- Drug4% Articaine with 1:200,000 epinephrine
Inferior Alveolar Nerve Block with 4% articaine
- Drug2% lidocaine with 1:100,000 epinephrine
Inferior Alveolar Nerve Block with 2% lidocaine
Locations (2)
- Cleveland Dental InstituteAkron, Ohio
- Cleveland Dental InstituteAshtabula, Ohio